• Illiquidity and inaccessibility of healthcare assets, limiting funding for innovation and hindering the development of life-changing treatments and therapies.
• Limited funding for innovation in the healthcare industry, leaving many promising projects and startups without necessary resources.
• Lack of liquidity for BioDAOs, limiting their ability to diversify portfolios and enhance investment strategies.
• Limited support for deal evaluation, making it difficult for average investors to effectively evaluate healthcare asset deals.
• Healthcare industry is heavily regulated and slow to adapt to new technologies, making it difficult to navigate and innovate.
• Increasing healthcare costs, placing a significant burden on individuals, families, and governments.
• Centralized control of the healthcare industry, stifling innovation and limiting access to care.

CareYield is an asset marketplace and innovation hub that tokenizes healthcare assets, creating a new class of liquid, investable assets that can be bought, sold, and traded on a marketplace. This unlocks a vast pool of capital, enabling healthcare innovators to access funding from new sources, especially crypto investors, to deliver care better, accelerate research, and bring new treatments to market.

• Development of the CareYield platform, with a focus on tokenization, deal valuation, and community building.
• Establishment of partnerships with key stakeholders, including institutional investors, HNW individuals, and crypto investors.
• Creation of a selection criteria and audit process for asset listing on the platform.